KalVista Pharmaceuticals KALV
-
-
-
已收盤：-
淨值比明細
年季 | 收盤價 | 權益總計(百萬) | 稅後權益報酬率(%) | 稅後純益(百萬) | 稅後資產報酬率(%) | 資產總計(百萬) |
|---|---|---|---|---|---|---|
| 2025Q2 | 11.31 | 41 | -88.26 | -60 | -25.78 | 216 |
| 2025Q1 | 11.54 | 95 | -43.43 | -52 | -19.83 | 251 |
| 2024Q4 | 8.47 | 145 | -34.76 | -49 | -22.21 | 276 |
| 2024Q3 | 11.58 | 134 | -27.55 | -42 | -23.41 | 161 |
| 2024Q2 | 11.78 | 173 | -21.32 | -40 | -18.57 | 200 |
| 2024Q1 | 11.86 | 207 | -30.25 | -45 | -25.56 | 235 |
| 2023Q4 | 12.25 | 89 | -28.59 | -29 | -22.97 | 114 |
| 2023Q3 | 9.63 | 114 | -21.79 | -28 | -18.49 | 139 |
| 2023Q2 | 9.00 | 139 | -16.86 | -25 | -14.74 | 160 |
| 2023Q1 | 7.86 | 161 | -15.23 | -26 | -13.61 | 183 |
| 2022Q4 | 6.76 | 184 | -12.98 | -21 | -11.63 | 203 |
| 2022Q3 | 14.51 | 144 | -14.43 | -22 | -12.90 | 163 |
| 2022Q2 | 9.84 | 165 | -13.18 | -23 | -11.93 | 182 |
| 2022Q1 | 14.74 | 185 | -12.27 | -24 | -11.24 | 204 |
| 2021Q4 | 13.23 | 208 | -10.32 | -22 | -9.58 | 225 |
| 2021Q3 | 17.45 | 227 | -8.33 | -20 | -7.81 | 244 |
| 2021Q2 | 23.96 | 244 | -6.42 | -16 | -6.07 | 259 |
| 2021Q1 | 25.69 | 257 | -9.47 | -15 | -8.84 | 272 |
| 2020Q4 | 18.99 | 59 | -16.26 | -10 | -14.19 | 66 |
| 2020Q3 | 12.59 | 65 | -14.96 | -10 | -13.09 | 75 |